The TGFB3 gene gives instructions for a signaling protein that helps cells grow, heal, and form tissues before birth. If it does not work properly, the roof of the mouth, blood vessels, bones, and skin may not develop or hold together in the usual way. This gene plays an important role in guiding how cells communicate during early development and tissue repair. Some pathogenic variants in the TGFB3 gene are linked to Loeys-Dietz syndrome, which can include a widened aorta and differences in the face, skeleton, or palate.
What is a gene?
Genes are stretches of DNA that provide cells with instructions for making molecules or regulating processes in the body. Some genes hold the code for proteins, the parts of cells that do much of the work. Others mainly control when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. You can find a deeper explanation of this topic in the LearnHub.
Overview
TGFB3Gene function
What if the gene works
Your cells use the TGFB3 gene to make a signaling protein that helps guide growth, tissue repair, and development. It is especially important as the palate, heart, and blood vessels form.
Risk
What if the gene does not work
Variants in the TGFB3 gene can cause a connective tissue condition with enlargement of the main artery (aorta) and a risk of aneurysm or tearing, sometimes with cleft palate. Milder and more severe variants can change the features and timing.
Treatment
What does that mean for your treatment
No TGFB3-specific treatment or drug-selection approach is currently established in clinical guidelines. Care is usually based on the person’s aortic and connective tissue findings, using standard heritable aortic disease management rather than a treatment chosen specifically for a TGFB3 variant. The TGFB3 gene is part of the TGF-β signaling pathway, which is being studied as a possible treatment target in related aortic conditions.
Conditions associated with TGFB3
Gene function
What if the gene works
Your cells use signals from the TGFB3 gene to coordinate how tissues grow, mature, and stay organized. This signaling is especially important while the body is forming and later when tissues need routine upkeep. Understanding what the TGFB3 gene does helps explain how cells communicate during tissue repair and development.
The TGFB3 gene makes a signaling protein that lets cells send instructions to nearby cells. These messages help tissues coordinate everyday tasks in an orderly way.
This gene helps control when cells grow, divide, or slow down. That balance supports normal tissue shape and keeps tissue upkeep more controlled.
TGFB3 signaling helps cells make and organize the extracellular matrix (the supportive material between cells). This supports strong, well-shaped tissues.
Signals linked to the TGFB3 gene help guide the normal steps of tissue repair after everyday wear or minor injury. They help cells coordinate rebuilding as a tissue settles back into place.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many do not cause any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more strongly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the TGFB3 gene can change how much signaling protein cells make, how stable it is, or how well it attaches to partner proteins. In practical terms, TGFB3 gene variant effects often mean weaker or uneven cell-to-cell signals that guide tissue growth and repair. Some variants have a milder functional effect, while more disruptive variants can greatly reduce protein output or activity and may be linked to earlier or broader features of TGFB3-related Loeys-Dietz syndrome.
How variants are linked to conditions
Pathogenic variants in the TGFB3 gene can cause Loeys-Dietz syndrome type 5, a connective tissue condition linked to enlargement of the aorta, a risk of aortic tear, and features such as flexible joints or changes in bone growth. Some variants in the TGFB3 gene are also found in families with thoracic aortic aneurysm and dissection. In TGFB3 gene variants and Loeys-Dietz syndrome, the main established concern is inherited aortic disease.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common across the general population. Most have no direct impact on health and simply reflect natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well characterized variant in a specific gene can be enough to confirm the diagnosis.
Are there things that can increase or change my risk?
For TGFB3, there is not yet broadly confirmed evidence on specific factors that clearly increase or reduce gene-related risk. Many living with a harmful TGFB3 change have a risk of blood vessel problems that is mainly linked to the variant itself, so regular follow-up and blood pressure control are often more important than lifestyle changes alone.
Inheritance of TGFB3 variants
TGFB3-related conditions are usually inherited in an autosomal dominant pattern. This means a person with a disease-causing variant in the TGFB3 gene can pass it on to each child with a 50% chance. In practical terms, how variants of the TGFB3 gene are inherited often means the change comes from one affected parent, though some people have a new variant that was not inherited from either parent. Sons and daughters are affected similarly because the TGFB3 gene is on chromosome 14.
What does my TGFB3 result mean for my family?
A disease-causing change in the TGFB3 gene is usually linked to a condition that can run in families in a dominant way, so close relatives such as parents, brothers, sisters, and children may also carry the same change. That can matter because some family members may have related heart, blood vessel, bone, or joint findings, even if symptoms differ from one person to another. In families with a confirmed TGFB3-related condition, relatives may want to discuss whether testing is appropriate for them.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the TGFB3 gene uses a blood sample, saliva sample, or cheek swab. A lab reads the DNA code of the TGFB3 gene and checks for changes that may help explain an inherited aortic condition or, in some families, cleft palate. Results may show a pathogenic variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Consider testing for changes in the TGFB3 gene if you or close relatives have had an enlarged aorta, the body's main artery, an aortic tear at a young age, or a pattern of blood vessel problems with very flexible joints or unusual bone features. A TGFB3 result can help explain an inherited connective tissue condition and guide family screening.
A genetic result is only one part of your health story
Genetic test results can provide useful insight, but how much they explain varies by the condition and the type of variant involved. Many other factors also shape how the body functions over time, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person but cause fewer benefits or more side effects for another. These differences are common and are one part of how clinicians understand medication response.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medicines. By studying links between genes and drugs, it helps explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support more informed, more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the TGFB3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so general questions about symptoms, treatment side effects, or medicine changes are best discussed with your doctor or pharmacist. Seek medical advice promptly for new or worsening symptoms, or before starting, stopping, or changing any prescribed treatment.
History
Researchers identified the TGFB3 gene in the late 1980s while sorting out the closely related members of the transforming growth factor beta family. Early studies showed that TGFB3 was distinct from TGFB1 and TGFB2, which helped scientists map a broader signaling system involved in human development. Building on this early work, scientists uncovered more about the gene through animal studies and human genetic research. In the 1990s and 2000s, TGFB3 drew more attention when variants in the gene were linked to cleft palate and later to inherited conditions affecting connective tissue and blood vessels. These findings placed the TGFB3 gene within the growing history of medical genetics, where careful family studies and DNA analysis connected visible traits with specific inherited variants.